[
    {
        "file_name": "harpoontherapeuticsinc_20200312_10-k_ex-10.18_12051356_ex-10.18_development agreement_option agreement.pdf",
        "perturbation": [
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "6.6\nRoyalty Payments and Reports. AbbVie shall calculate all amounts payable to Harpoon pursuant to\nSection 6.5 at the end of each [***], which amounts shall be converted to Dollars, in accordance with Section 6.7. AbbVie shall pay\nto Harpoon the royalty amounts due with respect to a given [***] within [***] after the end of such [***]. Each payment of royalties\ndue to Harpoon shall be accompanied by a statement of the amount of Net Sales of each Licensed Product in each country or other\njurisdiction the Territory during the applicable [***] (including such amounts expressed in local currency and as converted to Dollars)\nand a calculation of the amount of royalty payment due on such Net Sales for such [***], including the amount of any reductions\npursuant to Section 6.5.3.",
                "changed_text": "6.6\nRoyalty Payments and Reports. AbbVie shall calculate all amounts payable to Harpoon pursuant to\nSection 6.5 at the end of each [***], which amounts shall be converted to Dollars, in accordance with Section 6.7. AbbVie shall pay\nto Harpoon the royalty amounts due with respect to a given [***] within **180 days** after the end of such [***]. Each payment of royalties\ndue to Harpoon shall be accompanied by a statement of the amount of Net Sales of each Licensed Product in each country or other\njurisdiction the Territory during the applicable [***] (including such amounts expressed in local currency and as converted to Dollars)\nand a calculation of the amount of royalty payment due on such Net Sales for such [***], including the amount of any reductions\npursuant to Section 6.5.3.",
                "explanation": "The original text stipulates a payment timeline for royalty payments. By extending the payment deadline to **180 days**, the contract now contradicts standard business practices and potentially violates laws requiring timely payments.",
                "contradicted_law": "Potential violation of state laws regarding timely payment of royalties and standard accounting practices.",
                "location": "Section 6.6"
            },
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "6.11\nAudit. AbbVie shall, shall cause its Affiliates to, and shall use commercially reasonable efforts to\ncause its Sublicensees to, keep complete and accurate books and records pertaining to Net Sales of Licensed Products, in sufficient\ndetail to calculate all amounts payable hereunder. At the request of Harpoon, AbbVie shall permit an independent public accounting\nfirm of nationally recognized standing designated by Harpoon and reasonably acceptable to AbbVie, [***], to audit the books and\nrecords maintained pursuant to this Section 6.11 to ensure the accuracy of all reports and payments made hereunder, including any\npermitted deductions from Net Sales pursuant to Section 1.108. Such examinations may not (a) be conducted for any [***] [***] (b)\nbe conducted more than once in any [***] period or (c) be [***] (unless a previous audit revealed an underpayment with respect to\nsuch [***]). The accounting firm shall disclose to Harpoon only whether the reports are correct or not, and the specific details\nconcerning any discrepancies. No other information shall be shared. Except as provided below, the cost of this audit shall be borne by\nHarpoon, unless the audit reveals a variance [***] from the reported amounts or [***], in which case AbbVie shall bear the cost of\nthe audit.",
                "changed_text": "6.11\nAudit. AbbVie shall, shall cause its Affiliates to, and shall use commercially reasonable efforts to\ncause its Sublicensees to, keep complete and accurate books and records pertaining to Net Sales of Licensed Products, in sufficient\ndetail to calculate all amounts payable hereunder. At the request of Harpoon, AbbVie shall permit an independent public accounting\nfirm of nationally recognized standing designated by Harpoon and reasonably acceptable to AbbVie, [***], to audit the books and\nrecords maintained pursuant to this Section 6.11 to ensure the accuracy of all reports and payments made hereunder, including any\npermitted deductions from Net Sales pursuant to Section 1.108. Such examinations may not (a) be conducted for any [***] [***] (b)\nbe conducted more than once in any [***] period or (c) be [***] (unless a previous audit revealed an underpayment with respect to\nsuch [***]). The accounting firm shall disclose to **AbbVie** only whether the reports are correct or not, and the specific details\nconcerning any discrepancies. No other information shall be shared. Except as provided below, the cost of this audit shall be borne by\nHarpoon, unless the audit reveals a variance [***] from the reported amounts or [***], in which case AbbVie shall bear the cost of\nthe audit.",
                "explanation": "By modifying the text to state \"The accounting firm shall disclose to **AbbVie** only whether the reports are correct or not...\", the contract now prevents Harpoon from receiving vital information from the auditing process. This violates laws related to auditing and information disclosure.",
                "contradicted_law": "Sarbanes-Oxley Act (SOX) compliance and general principles of transparency in auditing.",
                "location": "Section 6.11"
            },
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "7.4\nInfringement Claims by Third Parties. If the manufacture, sale, or use of a Licensed Compound or\nLicensed Product in the Territory pursuant to this Agreement results in, or may result",
                "changed_text": "7.4\nInfringement Claims by Third Parties. If the manufacture, sale, or use of a Licensed Compound or\nLicensed Product in the Territory pursuant to this Agreement results in, or may result **without the need for providing prior notice of the infringement claims**",
                "explanation": "By adding the phrase, \"without the need for providing prior notice of the infringement claims,\" the contract eliminates a fundamental requirement of legal due process. Laws require giving prompt written notice to the other Party of the infringement claims.",
                "contradicted_law": "Violates standard legal procedures of due process and notification in intellectual property disputes.",
                "location": "Section 7.4"
            }
        ]
    }
]